Skip to main content

NYS Approves NIH, DOE Solicitations for 10-Percent State Funding Match


The New York State Economic Recovery and Investment Cabinet has approved four categories of funding under the American Recovery and Reinvestment Act — three from the National Institutes for Health, one from the Department of Energy — as eligible for additional state money equal to 10 percent of the federal award.

Awardees would receive $1 million from New York state, through Gov. David Paterson's new $100 million Innovation Economy Matching Grants program, for every $10 million in ARRA funding they win.

Eligible for the state matching funds is the National Institutes of Health, National Center on Minority Health and Health Disparities Community Participation in Health Disparities Intervention Research Planning (RFA-MD-09-006) due June 30. Funds are intended to support community-based participatory research to reduce and eliminate disparities in health care.

June 30 is the deadline for the Department of Energy Demonstration of Integrated Biorefinery Operations (DE-FOA-0000096). Funding for this program will support pilot and demonstration scale biorefinery projects.

Also eligible for matching funds are the NIH NCMHD Dissertation Research Award to Increase Diversity (RFA-MD-09-008) due June 30, designed to will fund life sciences doctoral research that advance the goals of the NCMHD; and the NIH NCMHD Exploratory Centers of Excellence (RFA-MD-09-007) due July 1. The purpose of those funds is to augment and expand the capacity and infrastructure for research that improves the health of the nation and for preparing the next generation of researchers.

To apply for a matching fund commitment letter, please go to the New York State Recovery website

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.